BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3342099)

  • 1. Adenosine metabolism in human whole blood. Effects of nucleoside transport inhibitors and phosphate concentration.
    Dawicki DD; Agarwal KC; Parks RE
    Biochem Pharmacol; 1988 Feb; 37(4):621-6. PubMed ID: 3342099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
    Dawicki DD; Agarwal KC; Parks RE
    Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
    Dawicki DD; Agarwal KC; Parks RE
    Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate.
    Plagemann PG
    J Cell Physiol; 1986 Sep; 128(3):491-500. PubMed ID: 3488996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of plasma adenosine in the antiplatelet activity of forskolin: potentiation by dipyridamole and dilazep.
    Agarwal KC; Zielinski BA; Maitra RS
    Thromb Haemost; 1989 Feb; 61(1):106-10. PubMed ID: 2749584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes.
    Gu JG; Nath A; Geiger JD
    J Neurochem; 1996 Sep; 67(3):972-7. PubMed ID: 8752102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
    Cass CE; King KM; MontaƱo JT; Janowska-Wieczorek A
    Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influx.
    Prus KL; Averett DR; Zimmerman TP
    Cancer Res; 1990 Mar; 50(6):1817-21. PubMed ID: 2306735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of nucleoside and nucleobase transport and nitrobenzylthioinosine binding by dilazep and hexobendine.
    Plagemann PG; Kraupp M
    Biochem Pharmacol; 1986 Aug; 35(15):2559-67. PubMed ID: 3741459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside transport in rat cerebral-cortical synaptosomes. Evidence for two types of nucleoside transporters.
    Lee CW; Jarvis SM
    Biochem J; 1988 Jan; 249(2):557-64. PubMed ID: 3342028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glucose uptake in murine cardiomyocyte cell line HL-1 by cardioprotective drugs dilazep and dipyridamole.
    Shuralyova I; Tajmir P; Bilan PJ; Sweeney G; Coe IR
    Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H627-32. PubMed ID: 14551048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
    Endres CJ; Sengupta DJ; Unadkat JD
    Biochem J; 2004 May; 380(Pt 1):131-7. PubMed ID: 14759222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of deoxycoformycin in human erythrocytes. Measurement by adenosine deaminase titration and radioisotope assays.
    Chen SF; Stoeckler JD; Parks RE
    Biochem Pharmacol; 1984 Dec; 33(24):4069-79. PubMed ID: 6334522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine.
    Plagemann PG; Woffendin C
    Biochim Biophys Acta; 1988 Apr; 969(1):1-8. PubMed ID: 3349106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of nucleoside transport sites into the host cell membrane of Babesia bovis infected erythrocytes.
    Gero AM
    Mol Biochem Parasitol; 1989 Jul; 35(3):269-76. PubMed ID: 2747745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes.
    Kalsi KK; Smolenski RT; Yacoub MH
    Mol Cell Biochem; 1998 Mar; 180(1-2):193-9. PubMed ID: 9546646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial action of nitrobenzylthioinosine in combination with purine nucleoside antimetabolites.
    Gero AM; Scott HV; O'Sullivan WJ; Christopherson RI
    Mol Biochem Parasitol; 1989 Apr; 34(1):87-97. PubMed ID: 2651920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside transport inhibition and fMLP-stimulated whole blood luminescence.
    Ver Donck KL; Verheyen WJ; Van Belle H
    J Mol Cell Cardiol; 1991 Jul; 23(7):783-5. PubMed ID: 1791629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxanthine enters human vascular endothelial cells (ECV 304) via the nitrobenzylthioinosine-insensitive equilibrative nucleoside transporter.
    Osses N; Pearson JD; Yudilevich DL; Jarvis SM
    Biochem J; 1996 Aug; 317 ( Pt 3)(Pt 3):843-8. PubMed ID: 8760371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.